๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

In vitro phase II trial of recombinant interferon alpha-2 in gastrointestinal cancer

โœ Scribed by W. Scheithauer; E. M. Temsch; K. Schieder; H. Funovics; R. Schiessel; G. Grabner

Book ID
112212008
Publisher
AlphaMed Press
Year
1985
Tongue
English
Weight
688 KB
Volume
3
Category
Article
ISSN
1066-5099

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Recombinant gamma interferon in advanced
Recombinant gamma interferon in advanced breast cancer: A phase II trial
โœ Hyman B. Muss; Mary Caponera; Patricia J. Zekan; Don V. Jackson; John J. Stuart; ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer US ๐ŸŒ English โš– 365 KB

Fifteen patients with advanced carcinoma of the breast who had failed prior chemotherapy, were treated with recombinant gamma interferon at a dose of 2mg/m2 (1mg = 2.4 X 10(7) international units) intravenously for five consecutive days every other week. The median patient age was 51 and all patient

A phase II study of recombinant human al
A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer
โœ Carol M. Van Haelst-Pisani; Ronald L. Richardson; John Su; Jan C. Buckner; Richa ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 306 KB ๐Ÿ‘ 2 views

To determine the efficacy of recombinant human leukocyte alpha-interferon (IFL-RA) in advanced hormone-refractory prostate cancer, the authors treated 40 patients with IFL-RA administered intramuscularly at a dose of 10 x 10' U/m2 three times weekly. Toxicity was substantial and necessitated at leas

A Phase II trial of 5-fluorouracil and r
A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma
โœ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 468 KB ๐Ÿ‘ 3 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do